Their study populations were patients with hyperthyroidism (including those with hyperactive nodules),4,8 or inpatients,15,19 and hepatic steatosis was defined using serum transaminase concentrations15 or both sonographic and serum ALT criteria.14 Contrastingly, our study only recruited newly diagnosed and untreated GD patients. The gene discussed is GPT; the disease is hyperthyroidism.